LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | PD0325901 | 0.37 | uM | LJP5 | 72 | hr | 1235 | 2560 | 4156 | 0.6160 | 0.4535 |
MCF7 | PD0325901 | 0.37 | uM | LJP6 | 72 | hr | 1235 | 2320 | 4156 | 0.5584 | 0.3716 |
MCF7 | PD173074 | 0.37 | uM | LJP6 | 72 | hr | 1235 | 4506 | 4156 | 1.0842 | 1.1198 |
MCF7 | PD184352 | 0.37 | uM | LJP5 | 72 | hr | 1235 | 3401 | 4156 | 0.8184 | 0.7416 |
MCF7 | Pelitinib | 0.37 | uM | LJP5 | 72 | hr | 1235 | 4330 | 4156 | 1.0420 | 1.0597 |
MCF7 | PF431396 | 0.37 | uM | LJP5 | 72 | hr | 1235 | 1632 | 4156 | 0.3927 | 0.1358 |
MCF7 | PF477736 | 0.37 | uM | LJP5 | 72 | hr | 1235 | 2037 | 4156 | 0.4901 | 0.2745 |
MCF7 | PF562271 | 0.37 | uM | LJP6 | 72 | hr | 1235 | 2418 | 4156 | 0.5819 | 0.4050 |
MCF7 | PHA-665752 | 0.37 | uM | LJP5 | 72 | hr | 1235 | 4574 | 4156 | 1.1006 | 1.1432 |
MCF7 | PHA-793887 | 0.37 | uM | LJP6 | 72 | hr | 1235 | 1216 | 4156 | 0.2927 | -0.0064 |
MCF7 | PI103 | 0.37 | uM | LJP6 | 72 | hr | 1235 | 1540 | 4156 | 0.3706 | 0.1044 |
MCF7 | PLX-4720 | 0.37 | uM | LJP5 | 72 | hr | 1235 | 4133 | 4156 | 0.9946 | 0.9923 |
MCF7 | QL-X-138 | 0.37 | uM | LJP6 | 72 | hr | 1235 | 1715 | 4156 | 0.4128 | 0.1644 |
MCF7 | QL-XII-47 | 0.37 | uM | LJP6 | 72 | hr | 1235 | 1131 | 4156 | 0.2722 | -0.0356 |
MCF7 | Radicicol | 0.37 | uM | LJP5 | 72 | hr | 1235 | 1603 | 4156 | 0.3857 | 0.1259 |
MCF7 | Radicicol | 0.37 | uM | LJP6 | 72 | hr | 1235 | 1601 | 4156 | 0.3854 | 0.1254 |
MCF7 | Seliciclib | 0.37 | uM | LJP5 | 72 | hr | 1235 | 3789 | 4156 | 0.9117 | 0.8743 |
MCF7 | Ruxolitinib | 0.37 | uM | LJP5 | 72 | hr | 1235 | 3973 | 4156 | 0.9561 | 0.9375 |
MCF7 | XL147 | 0.37 | uM | LJP5 | 72 | hr | 1235 | 4542 | 4156 | 1.0929 | 1.1322 |
MCF7 | Saracatinib | 0.37 | uM | LJP6 | 72 | hr | 1235 | 2013 | 4156 | 0.4845 | 0.2665 |
MCF7 | Selumetinib | 0.37 | uM | LJP6 | 72 | hr | 1235 | 2879 | 4156 | 0.6927 | 0.5627 |
MCF7 | Sirolimus | 0.37 | uM | LJP6 | 72 | hr | 1235 | 2499 | 4156 | 0.6013 | 0.4326 |
MCF7 | Sorafenib | 0.37 | uM | LJP6 | 72 | hr | 1235 | 3908 | 4156 | 0.9403 | 0.9150 |
MCF7 | SU11274 | 0.37 | uM | LJP5 | 72 | hr | 1235 | 4597 | 4156 | 1.1061 | 1.1509 |
MCF7 | Fedratinib | 0.37 | uM | LJP5 | 72 | hr | 1235 | 3512 | 4156 | 0.8452 | 0.7797 |